SHAPE THERAPEUTICS
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.
SHAPE THERAPEUTICS
Industry:
Biotechnology
Founded:
2018-04-05
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.shapetx.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
147.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Lazurite
Lazurite is a biotechnology company that creates the operating room of the future through smart surgical tools.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series B - Shape Therapeutics
Decheng Capital
Decheng Capital investment in Series B - Shape Therapeutics
Mission BioCapital
Mission BioCapital investment in Series B - Shape Therapeutics
Breton Capital Management
Breton Capital Management investment in Series B - Shape Therapeutics
Ling Wong
Ling Wong investment in Series B - Shape Therapeutics
Willett Advisors LLC
Willett Advisors LLC investment in Series B - Shape Therapeutics
Ling Wong
Ling Wong investment in Series A - Shape Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series A - Shape Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Series A - Shape Therapeutics
Tectonic Capital
Tectonic Capital investment in Series A - Shape Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-09 | Shape Therapeutics Appoints David J. Huss, Ph.D., as Chief Scientific Officer and Lisa Taylor Ash, J.D., as General Counsel |
Official Site Inspections
http://www.shapetx.com Semrush global rank: 5 M Semrush visits lastest month: 1.68 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Shape Therapeutics"
About - ShapeTX
Seattle. 700 Dexter Ave N Seattle, WA 98109 Boston. 17 Drydock Ave Boston, MA 02210See details»
ShapeTX's Leadership Team - Team members and org chart - The …
The leadership team at ShapeTX has experience in a wide range of industries and education. They have worked at companies such as Bristol Myers Squibb, Celgene, Juno Therapeutics, …See details»
ShapeTX - The Org
ShapeTX 1 follower Shape Therapeutics is a biotechnology company developing next-generation RNA-targeted therapies to treat the world’s most challenging diseases.See details»
Shape Therapeutics - Crunchbase Company Profile & Funding
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic …See details»
Shape Therapeutics Inc. | LinkedIn
The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as …See details»
ShapeTX Company Profile 2024: Valuation, Funding & Investors
ShapeTX General Information Description. Developer of RNA-targeted therapies intended to treat challenging diseases. The company's platform includes a proprietary suppressor technology …See details»
Shape Therapeutics Inc. Information - RocketReach
ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze …See details»
Shape Therapeutics Appoints Healthcare Industry Leaders David …
Jun 25, 2024 Todd Simpson brings more than 40 years of diverse life sciences and industry experience to the ShapeTX board. During his nearly two decades at Seagen, Todd played a …See details»
Shape Therapeutics Appoints David J. Huss, Ph.D., as Chief …
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, …See details»
Big strides, new website, same core mission - ShapeTX
Oct 25, 2022 At ShapeTX, we recognize that the key to unlocking effective gene therapies lies at the intersection of innovating each component of a programmable medicine – the RNA (the …See details»
Shape Therapeutics - Overview, News & Similar companies
Aug 5, 2023 The ShapeTX gene therap y platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, …See details»
Shape Therapeutics Inc. Company Profile: , Investments, Contact ...
ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze …See details»
ShapeTX Expands Strategic Collaboration with Roche with …
SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- ShapeTX announced today the expansion of its partnership with Roche, with Roche adding a new target to their ongoing collaboration, …See details»
Shape Therapeutics Appoints Healthcare Industry Leaders
SEATTLE, June 25, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, Inc. (ShapeTX), a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, announces the …See details»
Shape Therapeutics Secures $112 Million in Series B
SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of...See details»
Shape Therapeutics Secures $112 Million in Series B Financing to ...
SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, …See details»
Taking gene therapy to the next level - Nature
ShapeTX’s three key areas of work. RNA editing tools, tissue-specific AAVs and manufacturing technology (end-to-end approach). AAV, adeno-associated viruses; AI, artificial intelligence.See details»
Company News - ShapeTX
Jan 5, 2023 ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing the Potential of Generative AI and RNA in CNS Disorders and Beyond January 5, 2023 ShapeTX …See details»
Recommended Stories - Yahoo Finance
Apr 30, 2024 “Over the past five years, ShapeTX has laid the foundation to revolutionize the field of RNA therapies,” said David Huss, PhD, CSO at ShapeTX. “The time is now to capitalize on …See details»